Clinical Trials Browser

Has results × Kidney Neoplasms × Erlotinib Hydrochloride × Clear all

NCT01130519 2025-02-21

A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer

Phase 2 Completed

83 enrolled 17 charts

Hereditary leiomyomatosis and renal cell cancer, Carcinoma, Renal Cell, Kidney Neoplasms

NCT00425386 2017-05-03

Sunitinib and Erlotinib in Treating Patients With Unresectable or Metastatic Kidney Cancer

Phase 2 Completed

60 enrolled 10 charts

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00045487 2014-01-27

OSI-774

Phase 2 Completed

41 enrolled 7 charts

Carcinoma, Renal Cell, Kidney Neoplasms